Trial of Theracurmin for Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT04499963 · COMPLETED

Trial details

NCT number: NCT04499963
Sponsor: Richard Bedlack, M.D., Ph.D.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-08-28
Primary completion: 2022-08-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.